miR-335-5p通过复杂调控通路在根尖周病变中发挥双重作用
本研究探讨miR-335-5p在根尖周炎中的功能与调控机制,从人牙周膜成纤维细胞、10例根尖周炎组织和6例健康牙周膜组织提取RNA,用双荧光素酶报告基因、Western blot和ELISA检测。结果显示miR-335-5p是炎症正调控因子,直接靶向uPAR和RANKL,并通过FXR1介导uPAR的去抑制,在根尖周炎中发挥双重作用。
要点
- miR-335-5p在HPDLF炎症中起正调控作用,并直接靶向uPAR和RANKL。
- 炎症刺激下FXR1介导uPAR去抑制,miR-335-5p无论炎症与否均促进RANKL。
- miR-335-5p、uPAR、RANKL和FXR1在HPDLF炎症与根尖周炎组织中表达谱一致。
核心结论
- miR-335-5p可能通过双重角色参与根尖周炎,并可能成为临床治疗靶点。
研究设计与样本
- 从人牙周膜成纤维细胞、10例根尖周炎组织和6例健康牙周膜组织提取总RNA。
- 采用实时PCR、双荧光素酶报告基因、Western blot和ELISA检测基因与蛋白表达。
- 数据采用Student t检验分析。
主要发现
- miR-335-5p在HPDLF炎症中作为正调控因子(P < .05)。
- 鉴定出miR-335-5p的两个靶点uPAR和RANKL。
- uPAR在基础水平被miR-335-5p抑制,但脂多糖刺激下可发生去抑制。
- miR-335-5p无论有无炎症均促进HPDLF中RANKL表达(P < .05)。
- FXR1介导uPAR从miR-335-5p的去抑制(P < .01),且FXR1和uPAR均为HPDLF炎症正调控因子(P < .05)。
关键数值与推荐
- miR-335-5p在HPDLF炎症中正调控(P < .05)。
- miR-335-5p促进RANKL表达(P < .05)。
- FXR1介导uPAR去抑制(P < .01)。
- FXR1和uPAR为正调控因子(P < .05)。
- miR-335-5p、uPAR、RANKL和FXR1在HPDLF炎症与根尖周炎组织中表达谱一致(P < .05)。
临床怎么用
- miR-335-5p可能作为根尖周炎临床治疗的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: MicroRNA-335-5p has been reported to regulate osteogenic and chondrogenic differentiations of mesenchymal stem cells. The aim of this study was to explore the function and regulation mechanism of miR-335-5p in apical periodontitis (AP). METHODS: Total RNAs were extracted from human periodontal ligament fibroblasts (HPDLFs), 10 AP tissues, and 6 healthy periodontal ligament tissues using lysis buffer. Gene expression was detected using real-time polymerase chain reaction. The Dual Luciferase Assay (Promega, Madison, WI) was used to test miR-335-5p directly targeted urokinase-type plasminogen activator receptor (uPAR) and the receptor activator of nuclear factor kappa-B ligand (RANKL). Western Blot was used to detect protein expressions of RANKL, uPAR, and the fragile X-related 1 gene (FXR1). The enzyme-linked immunosorbent assay was used to detect the secretions of interleukin 6, tumor necrosis factor alpha, and RANKL. Data were analyzed using the Student t test. RESULTS: miR-335-5p acted as a positive mediator in HPDLF inflammation (P < .05). Two targets of miR-335-5p, uPAR and RANKL, were identified. Interestingly, uPAR was repressed by miR-335-5p at the basal level, but it can be relieved from miR-335-5p-mediated repression, which is called derepression, when HPDLFs were subjected to lipopolysaccharide stimulation. miR-335-5p promoted RANKL in HPDLFs regardless of whether or not it was under inflammatory conditions (P < .05). We proved FXR1 was responsible for the derepression of uPAR from miR-335-5p (P < .01). Both FXR1 and uPAR were positive mediators in HPDLF inflammation (P < .05). miR-335-5p, uPAR, RANKL, and FXR1 had the same expression profiles in HPDLF inflammation and AP tissues (P < .05). CONCLUSIONS: Our data showed that miR-335-5p may play dual roles in AP, and it might be considered as a target for therapeutic potency in clinical applications.
引用
- Yue J, Wang P, Hong Q, et al. MicroRNA-335-5p Plays Dual Roles in Periapical Lesions by Complex Regulation Pathways. J Endod. 2017. PMID: 28578884. doi:10.1016/j.joen.2017.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。